RXI PHARMACEUTICALS CORP (RXII) SEC filings
RXII SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RXII overview →
No RXII SEC filing events in the measured window.
Nothing matched in the current window — the RXII overview has every event we measure for this name.
Get an email when RXII moves on news →Keep exploring
More RXII: earnings → · analyst actions → · RXII overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AKERS BIOSCIENCES INC COMMON S (AKER) | 478 | -0.87% | 33% |
| Axon Enterprise, Inc. (AXON) | 478 | -0.04% | 48% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 477 | -0.11% | 46% |
| Ascendis Pharma A/S - Ordinary Share (ASND) | 474 | -0.08% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.